Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Capital Employed (2024 - 2025)

Inhibrx Biosciences (INBX) has disclosed Return on Capital Employed for 2 consecutive years, with 1.05% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 101.0% to 1.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.05% through Dec 2025, up 101.0% year-over-year, with the annual reading at 1.04% for FY2025, 59.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 1.05% at Inhibrx Biosciences, down from 0.97% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.89% in Q2 2025, with the low at 2.06% in Q4 2024.